Literature DB >> 10095078

Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons.

L Feng1, C Y Wang, H Jiang, C Oho, K Mizuno, M Dugich-Djordjevic, B Lu.   

Abstract

Previous studies have shown that brain derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) can enhance the survival of dopaminergic neurons in the ventral mesencephalon (VM). Here we compared several non-survival functions of the two factors in VM neurons in culture. We found that both BDNF and GDNF elicited an increase in the depolarization-induced release of dopamine, but had no effect on GABA release, in the VM cultures. BDNF, but not GDNF, significantly enhanced the expression of the calcium binding protein calbindin and synaptic protein SNAP25. In contrast, treatment of the cultures with GDNF, but not BDNF, elicited a marked fasciculation of the processes of the VM neurons. Thus, although both act on VM neurons, BDNF and GDNF have distinct functions. Copyright 1999 Published by Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095078     DOI: 10.1016/s0169-328x(99)00015-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  15 in total

1.  Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.

Authors:  R E J Musgrove; A E King; T C Dickson
Journal:  Neurotox Res       Date:  2010-07-09       Impact factor: 3.911

2.  Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain.

Authors:  Suzanne Numan; Christine M Gall; Kim B Seroogy
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Location and Number of Astrocytes Determine Dopaminergic Neuron Survival and Function Under 6-OHDA Stress Mediated Through Differential BDNF Release.

Authors:  Indrani Datta; Kavina Ganapathy; Rema Razdan; Ramesh Bhonde
Journal:  Mol Neurobiol       Date:  2017-09-30       Impact factor: 5.590

4.  Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

Authors:  Zachary C Baquet; Paula C Bickford; Kevin R Jones
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

5.  Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice.

Authors:  Manami Abe; Hiroki Kimoto; Risa Eto; Taeko Sasaki; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

Review 6.  Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse.

Authors:  E M Nikulina; C E Johnston; J Wang; R P Hammer
Journal:  Neuroscience       Date:  2014-05-27       Impact factor: 3.590

7.  The timing and location of glial cell line-derived neurotrophic factor expression determine enteric nervous system structure and function.

Authors:  Hongtao Wang; Inna Hughes; William Planer; Alexander Parsadanian; John R Grider; Bhupinder P S Vohra; Cynthia Keller-Peck; Robert O Heuckeroth
Journal:  J Neurosci       Date:  2010-01-27       Impact factor: 6.167

8.  Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons.

Authors:  J Du; L Feng; F Yang; B Lu
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

9.  A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs).

Authors:  Deborah Prè; Michael W Nestor; Andrew A Sproul; Samson Jacob; Peter Koppensteiner; Vorapin Chinchalongporn; Matthew Zimmer; Ai Yamamoto; Scott A Noggle; Ottavio Arancio
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

10.  Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications.

Authors:  Pim R A Heckman; Marlies A van Duinen; Eva P P Bollen; Akinori Nishi; Lawrence P Wennogle; Arjan Blokland; Jos Prickaerts
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-02       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.